150 related articles for article (PubMed ID: 10455285)
21. Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.
Cusack NJ; Hourani SM
Br J Pharmacol; 1981 Jun; 73(2):409-12. PubMed ID: 7236993
[TBL] [Abstract][Full Text] [Related]
22. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
23. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
[TBL] [Abstract][Full Text] [Related]
24. The stable pyrimidines UDPbetaS and UTPgammaS discriminate between contractile cerebrovascular P2 receptors.
Malmsjö M; Hou M; Pendergast W; Erlinge D; Edvinsson L
Eur J Pharmacol; 2003 Jan; 458(3):305-11. PubMed ID: 12504787
[TBL] [Abstract][Full Text] [Related]
25. Human Ntera-2/D1 neuronal progenitor cells endogenously express a functional P2Y1 receptor.
Moore DJ; Chambers JK; Murdock PR; Emson PC
Neuropharmacology; 2002 Nov; 43(6):966-78. PubMed ID: 12423666
[TBL] [Abstract][Full Text] [Related]
26. P2Y- and P2U-mediated increases in internal calcium in single bovine aortic endothelial cells in primary culture.
Duchêne AD; Takeda K
Endothelium; 1997; 5(4):277-86. PubMed ID: 9588819
[TBL] [Abstract][Full Text] [Related]
27. Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.
Wirkner K; Schweigel J; Gerevich Z; Franke H; Allgaier C; Barsoumian EL; Draheim H; Illes P
Br J Pharmacol; 2004 Jan; 141(1):141-51. PubMed ID: 14662731
[TBL] [Abstract][Full Text] [Related]
28. The P2Y1 receptor is an ADP receptor antagonized by ATP and expressed in platelets and megakaryoblastic cells.
Léon C; Hechler B; Vial C; Leray C; Cazenave JP; Gachet C
FEBS Lett; 1997 Feb; 403(1):26-30. PubMed ID: 9038354
[TBL] [Abstract][Full Text] [Related]
29. Two distinct P2 purinergic receptors, P2Y and P2U, are coupled to phospholipase C in mouse pineal gland tumor cells.
Suh BC; Son JH; Joh TH; Kim KT
J Neurochem; 1997 Apr; 68(4):1622-32. PubMed ID: 9084434
[TBL] [Abstract][Full Text] [Related]
30. Evidence for separate calcium-signaling P2T and P2U purinoceptors in human megakaryocytic Dami cells.
Murgo AJ; Contrera JG; Sistare FD
Blood; 1994 Mar; 83(5):1258-67. PubMed ID: 8118030
[TBL] [Abstract][Full Text] [Related]
31. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.
Baurand A; Eckly A; Bari N; Léon C; Hechler B; Cazenave JP; Gachet C
Thromb Haemost; 2000 Sep; 84(3):484-91. PubMed ID: 11019976
[TBL] [Abstract][Full Text] [Related]
32. Evidence for a P2-purinoceptor mediating vasoconstriction by UTP, ATP and related nucleotides in the isolated pulmonary vascular bed of the rat.
Rubino A; Burnstock G
Br J Pharmacol; 1996 Jul; 118(6):1415-20. PubMed ID: 8832066
[TBL] [Abstract][Full Text] [Related]
33. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
Sanderson HM; Heptinstall S; Vickers J; Lösche W
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of ATP receptors in ampulla from frog semicircular canal.
Butlen D; Bernard C; Ferrary E
Am J Physiol; 1998 Jul; 275(1):R253-61. PubMed ID: 9688986
[TBL] [Abstract][Full Text] [Related]
35. Effect of purinergic agonists and antagonists on insulin secretion from INS-1 cells (insulinoma cell line) and rat pancreatic islets.
Verspohl EJ; Johannwille B; Waheed A; Neye H
Can J Physiol Pharmacol; 2002 Jun; 80(6):562-8. PubMed ID: 12117305
[TBL] [Abstract][Full Text] [Related]
36. Characterization of purinoceptors mediating depolarization of rat isolated vagus nerve.
Trezise DJ; Kennedy I; Humphrey PP
Br J Pharmacol; 1993 Nov; 110(3):1055-60. PubMed ID: 8298793
[TBL] [Abstract][Full Text] [Related]
37. Two types of relaxation-mediating P2 receptors in rat gastric circular muscle.
Otsuguro K; Ohta T; Ito S; Nakazato Y
Jpn J Pharmacol; 1998 Oct; 78(2):209-15. PubMed ID: 9829624
[TBL] [Abstract][Full Text] [Related]
38. The P2Y12 antagonists, 2-methylthioadenosine 5'-monophosphate triethylammonium salt and cangrelor (ARC69931MX), can inhibit human platelet aggregation through a Gi-independent increase in cAMP levels.
Srinivasan S; Mir F; Huang JS; Khasawneh FT; Lam SC; Le Breton GC
J Biol Chem; 2009 Jun; 284(24):16108-16117. PubMed ID: 19346255
[TBL] [Abstract][Full Text] [Related]
39. The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.
Hechler B; Léon C; Vial C; Vigne P; Frelin C; Cazenave JP; Gachet C
Blood; 1998 Jul; 92(1):152-9. PubMed ID: 9639511
[TBL] [Abstract][Full Text] [Related]
40. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]